Peg Filtero 6mg Injection

Product Description

Peg Filtero 6mg Injection contains Pegfilgrastim, a long-acting form of filgrastim, which is a granulocyte colony-stimulating factor (G-CSF). Pegfilgrastim is used primarily to reduce the risk of infection in patients undergoing chemotherapy by stimulating the bone marrow to produce more white blood cells (neutrophils).

Inform your healthcare team about all medications you take due to potential interactions. This medication is not recommended during pregnancy or breastfeeding, and effective contraception is advised; avoid driving if you experience dizziness.

Brand Name: Peg Filtero

Composition: Pegfilgrastim

Mechanism of Action:

A pegylated version of filgrastim, pegfilgrastim promotes the development, maturation, and activation of bone marrow-derived neutrophils, a subset of white blood cells. This lowers the risk of infections by shortening the length of neutropenia, or low neutrophil count, that is linked to chemotherapy.

Uses:

• Chemotherapy-Induced Neutropenia
• Bone Marrow Transplantation

Dosage and Administration:

Typically administered as a single subcutaneous injection per chemotherapy cycle, usually 24 hours after the completion of chemotherapy.

Side Effects:

• Bone pain
• Headache
• Nausea
• Fatigue
• Injection site reactions.
• Splenic rupture
• Acute respiratory distress syndrome ARDS
• Sickle cell disease
• Capillary leak syndrome.